Cov yam ntxwv ua haujlwm
Kev kuaj pom txwv: 5ng / mL;
Linear Ntau: 5.00 ~ 400.00 ng / mL;
Kab rov tav coefficient R ≥0.990;
Precision: hauv batch CV yog ≤15%;nruab nrab ntawm pawg CV yog ≤20%;
Qhov tseeb: qhov sib txawv ntawm qhov ntsuas qhov ntsuas yuav tsum tsis pub tshaj ± 15% thaum ntsuas qhov ntsuas qhov tseeb ntawm tus qauv.
1. Khaws lub ntes tsis nyob ntawm 2 ~ 30 ℃.Qhov tsis yog ruaj khov mus txog 18 lub hlis.
2. Khaws Aehealth Ferritin Rapid Quantitative test cassette ntawm 2 ~ 30 ℃, txee lub neej yog txog 18 lub hlis.
3. Cov ntawv xeem yuav tsum siv li ntawm 1 teev tom qab qhib lub pob.
ST2 yog ib tug tswv cuab ntawm Tus Hu-zoo li receptor/interleukin-1 (interleukin-1, IL-1) receptor superfamily.IL-33 yog nws qhov tshwj xeeb ua haujlwm ligand thiab tau zais los ntawm cardiomyocytes thiab fibroblasts.Ob yam khoom ntawm cov noob qhia: transmembrane ST2 (ST2L) thiab sST2.ST2L muaj peb qhov ntxiv ntawm immunoglobulin domains, thaum sST2 tsis muaj transmembrane thiab intracellular receptor domains.Lawv khi rau cov ligand IL-33 thiab ua lub luag haujlwm lom neeg.ST2L thiab IL-33 kev taw qhia txoj kev muaj cov teebmeem cardioprotective xws li tiv thaiv cardiomyocyte hypertrophy, myocardial fibrosis thiab tiv thaiv atherosclerosis.Thaum lub plawv load nce, sST2 secretion nce, thiab nce sST2 tiv thaiv IL-33 los ntawm kev sib txuas nrog ST2L, yog li tiv thaiv cov nyhuv cardioprotective ntawm IL-33 / ST2L signaling pathway.Nws yog inferred tias sST2 tej zaum yuav yog ib tug pathogenic mediator ntawm cardiomyocyte hypertrophy thiab myocardial fibrosis.Kev txiav txim siab ntau ntawm sST2 qib tuaj yeem muab cov kws kho mob nrog cov cuab yeej raug los pab hauv kev ntsuas ntawm lub plawv tsis ua haujlwm.